Zydus Lifesciences Limited (BOM: 532321)

Zydus Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	979,569	1,013,630	497,549	356,774	451,368	273,595
Market Cap Growth	72.72%	103.72%	39.46%	-20.96%	64.98%	-22.99%
Enterprise Value	979,824	1,022,435	525,557	387,118	504,363	344,184
Last Close Price	973.90	1002.75	485.75	342.17	430.07	260.57
PE Ratio	22.76	26.26	25.38	7.95	21.16	23.25
PS Ratio	5.00	5.19	2.89	2.36	3.13	1.92
PB Ratio	4.45	4.59	2.53	1.87	3.02	2.34
P/TBV Ratio	7.89	8.48	4.28	3.40	7.04	7.61
P/FCF Ratio	33.83	43.67	30.01	39.56	18.50	13.49
P/OCF Ratio	23.41	31.40	18.50	16.95	13.70	9.33
EV/Sales Ratio	4.56	5.23	3.05	2.56	3.50	2.41
EV/EBITDA Ratio	15.51	19.45	14.87	12.21	14.77	12.47
EV/EBIT Ratio	17.82	22.52	18.42	15.65	18.44	16.38
EV/FCF Ratio	30.83	44.05	31.70	42.92	20.67	16.98
Debt / Equity Ratio	0.01	0.04	0.06	0.22	0.31	0.68
Debt / EBITDA Ratio	0.03	0.16	0.34	1.33	1.35	2.89
Debt / FCF Ratio	0.06	0.35	0.72	4.68	1.89	3.95
Asset Turnover	0.75	0.71	0.64	0.58	0.61	0.60
Inventory Turnover	1.80	1.87	1.81	1.63	1.64	1.86
Quick Ratio	1.34	1.30	1.05	0.96	0.57	0.62
Current Ratio	2.27	2.14	1.81	1.54	1.11	1.05
Return on Equity (ROE)	19.57%	18.90%	10.82%	13.96%	16.91%	10.30%
Return on Assets (ROA)	11.74%	10.31%	6.66%	5.98%	7.19%	5.57%
Return on Capital (ROIC)	14.80%	12.95%	8.08%	7.22%	8.71%	6.68%
Earnings Yield	4.38%	3.81%	3.94%	12.58%	4.73%	4.30%
FCF Yield	2.96%	2.29%	3.33%	2.53%	5.41%	7.41%
Dividend Yield	0.00%	0.30%	1.24%	0.73%	0.81%	1.34%
Payout Ratio	7.05%	16.09%	13.63%	8.29%	0.07%	60.74%
Buyback Yield / Dilution	0.31%	0.37%	0.79%	-	-	-
Total Shareholder Return	0.31%	0.67%	2.03%	0.73%	0.81%	1.34%

Source: S&P Capital IQ. Standard template. Financial Sources.